Proximal Right Coronary Artery Conduit

Known as: PRCA, Proximal Right Coronary Artery Conduit Segment 
The section of the right coronary artery proximal to the origin of the right ventricular artery.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
020406019732017

Related topics

Related topics

5 relations
Body partCDISC SDTM Anatomical Location TerminologyClinical Data Interchange Standards Consortium TerminologyHeart
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Proximal Right Coronary Artery Conduit
Heart
Body part
CDISC SDTM Anatomical Location Terminology
Vascular System
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
LBA2 Background: Docetaxel (D) improves OS of men with mPrCa who have progressed on androgen deprivation therapy (ADT). We aimed… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.
It was recently demonstrated that antiestrogens prevented prostate cancer (PRCA) in men. The source of estradiol (E2) that… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
There is a high and rising prevalence of prostate cancer (PRCA) within the male population of the United Kingdom. Although the… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.
BACKGROUND The incidence of pure red cell aplasia (PRCA) in chronic kidney disease patients treated with epoetins increased… (More)
Is this relevant?
2005
2005
Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
A substantial increase in the incidence of pure red cell aplasia (PRCA) associated with recombinant human erythropoietin (epoetin… (More)
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
The RNASEL gene (2',5'-oligoisoadenylate-synthetase dependent) encodes a ribonuclease that mediates the antiviral and apoptotic… (More)
Is this relevant?
2001
2001
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
The ELAC2/HPC2 gene at 17p11 is the first candidate gene identified for human prostate cancer (PRCA) based on linkage analysis… (More)
  • table 2
  • table 1
  • table 3
Is this relevant?
2001
2001
Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.
Immune-mediated, acquired pure red cell aplasia (PRCA) is a rare disorder frequently associated with other autoimmune phenomena… (More)
  • figure 1
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
Recent studies suggest that hereditary prostate cancer is a complex disease involving multiple susceptibility genes and variable… (More)
Is this relevant?
1998
1998
Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells
The malignant phenotype of prostatic tumor cells correlates with the expression of both uPA and itscell-membrane receptor (uPAR… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?